Stocks Moving From Alpha-Rich Ideas
Last Monday, Ravee Mehta called Autobytel a potential long-term triple, with near-term catalysts as well. The stock is +15.8% since. Read article »
On September 30, tech expert Ashraf Eassa said newly public Violin Memory was overvalued and a strong short play. After being nearly halved following its most recent earnings report, the shares are -54.3% to date. Read article »
Breaking Alpha-Rich Ideas (for PRO Subscribers) Learn more »
This Company Has Several Near And Long-Term Catalysts To Reward Shareholders by Alpha Gen Capital
Outlook Remains Strong At This Company Despite Recent Outperformance by Richard Zeits
4 Reasons This Could Be A Multi-Bagger by Joe Springer
Great Potential In This Focused Retailer by Helix Investment Research
Long Ideas
Johnson & Johnson Vs. Pfizer, Bristol In The Race Of Anticoagulants by Peter Geschek
Is CETA Great News For Rogers Sugar? by William Koenig
Cisco: What Should Investors Do Now? by Bill Maurer
Insiders Are Buying Perseus Mining - Should You? by Steve Nicastro
Akamai: Bullish But Waiting On A Safety Margin by Bottom Up Investing
Here's Why Hedge Funds Have Been Buying Ulta Over The Past 6 Months by Leigh Drogen
DataWatch Quarterly Review: Rapid Growth Finally Materializing by Galileo Russell
Is 'Apples To Oranges' Really The Best Biotechnology Investment Strategy? by Brian Nichols
Intel: Another Lie You Shouldn't Believe by Ashraf Eassa
Medifocus Incorporated: Not Your Typical Nano-Cap by The Behavioral Economist
Top Gold Stock For 2014: Gran Colombia Gold by Steve Nicastro
Saga Communications: Situated To Benefit From Consolidation In Traditional Media - But Wait A Couple Of Weeks by ValueArtifex
Apple: Not Out Of The Woods Yet by Ashraf Eassa
Himax: Non-Display Driver Business Key To Long-Term Growth by Marsha Robe
GameStop Hopeful On Strong Sales Of New Consoles by Trefis
Alcoa: Time To Regain Lost Glory by Marsha Robe
Kingold Jewelry Is Fundamentally Undervalued, But Not For Long by Samuel Rae
Manitex Wobbles A Bit, But Still A Share-Gaining Industrial Growth Story by Stephen Simpson, CFA
Glivec Generics May Be Delayed In The U.S. - Buy Novartis by Pharma Intelligence
IBM: A History Of Adapting, Extinction Seems Unrealistic by Charles Margolis
Osiris Focuses On Biosurgery After Selling Prochymal, Stock Attractively Valued by Andy Batts
Ruger And Smith & Wesson: More Upside Ahead by Davin Flynn
Microsoft May Surprise To The Upside This Quarter by Michael Blair
Is Intel Starting A Price War In Mobile Processors? by Sneha Shah
The Great Bull Vs. Bear Debate On Premier Exhibitions by Chris DeMuth Jr.
Vertex: CF Drug Approval To Save The Company by Balanced Investing
Unilife: Set To Double In 2014? by Dr. Thomas Carr
3 Reasons Nuance Is Bottoming From Here by Chris Lau
There Is Safety In Disruption: A High-Level Tesla Valuation by Daniel Weidelich
Camtek: Untangling The 3-D Printing Story by Jonathan Fishman
7 Reasons Why Groupon Is A Buy by R.J. Chopin
Orexigen Announces $100 Million Offering by Spencer Osborne
2014: A Watershed Year For Energy Recovery by Esekla
Looking For An International Growth Investment? Take A Look At Agria Corporation by John Mylant
Materion's Opportunities In Specialty Materials Well Worth Watching by Stephen Simpson, CFA
Neonode: Clearing Up The Confusion Ahead Of Imminent New Product Ramps by Tech Guru
Wellesley Bank Won't Be Trading Below Book Value For Long by Stephen Rosenman
Why Investors May Want To Upgrade Alcatel-Lucent To A Buy by Leah Frakes
Barely Followed, Crown Crafts Worth A Closer Look by Stephen Simpson, CFA
Arena's Belviq Script Sales Hit Milestones by Spencer Osborne
Recent Events Are Big Opportunities For MiMedx To Increase Market Share, Revenue Growth by Dave Kelly
Look At Fuel Cell Energy To Take Advantage Of The Energy Revolution by Mike Hathaway
Intel: Thoughts On Capex, R&D, Segment Performance And Valuation by Tom Armistead
Is Rosetta Resources Ready To Bloom? by Clayton Rulli
With Signs Of Growth Slowing, How Can Facebook Grow Its Revenue? by Patrick Salyer
Q2 Earnings Release Will Trigger Smith & Wesson's Upside Potential by Pim Keulen
Warren Buffett's (Hypothetical) Answer To Arne Alsin's Letter On IBM by Early Retiree
Ascena Retail Group: Expansion Into Boys Clothing Should Not Be Ignored by Chris Katje
Can Bank Of America Double After Resolving Legal Issues? by Quoth the Raven
At Least 20% Upside For ValueClick by Always Bullish
OvaScience: Still On The Sidelines Because Of The "Minimal Manipulation" Controversy by Mad Titan
Why Amerco Still Has More Upside by Tony Tuozhi Yang
Miller Industries: Zero Debt To Tow by Patrick Rooney
Higher Than Expected Result Unleashes Bulls For This Stock by Balanced Investing
ImmunoCellular Is A High Risk, High Reward Biopharma by EnhydrisPECorp
Why Software Defined Networks Are Good For Cisco by Zeus Kerravala
Northwest Biotherapeutics: Where From Here? by Stock Whisper
MFC Industrial: Will Peter Kellogg's Recent Shareholder Activism Unlock Shareholder Value? by Cowboy Investing
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug by James Banjo
Splunk's Stock Rising Despite Growing Losses by Sramana Mitra
SodaStream Shelf Space Expanding Through Black Friday by Seth Golden
Simplicity Bancorp: An Overcapitalized Bank Ripe For A Takeover by Gregory Vousvounis
Will Starbucks Assembly-Line Coffee System Hurt Investors? by Marty Frantz
Short Ideas
PDL BioPharma Is Severely Overvalued by Ruerd Heeg
The Eastern Co. Weighed Down By $7.5M In Debt by Patrick Rooney
Barron's Recommendation Of Approach Resources Is Underperforming, Better Value Indeed Elsewhere by Josh Young
Merck: The Good, The Bad And The Ugly by Pharma Reports
Amarin: Don't Follow The Leader by Quoth the Raven
The Anatomy Of A Bi-Polar Herbalife Filing by Quoth the Raven
Auxilium: Serious Red Flags Make The Upcoming FDA Decision For Xiaflex A 'High Risk' by Ben Yoffe
China Zenix: The Bears Are Not Done Yet by Investing Insight
Tesla's Valuation Continues To Defy Logic by Stone Fox Capital
Quick Picks & Lists
Steel Stocks: Head Fake Or Legitimate Breakout? by Lou Basenese
Japan Vs. South Korea: Who Will Win The Lithium-Ion Battery War? by Juan Carlos Zuleta
4G Awards To Test China In 2014 by Doug Young
Social Media Darling Stocks Compared - Twitter Vs. LinkedIn Vs. Facebook Using Google As A Benchmark by Siddharth Dalal
1 Asian-American Bank Excels Far Beyond The Pack by The Capitalist
I Am Not Excited About Deere & Co.'s Growth Prospects For 2014 by John Mylant
Oversold Target Could Be A Winner This Holiday Season by David Eller
Microsoft And Apple: Correction Soon Before New Highs? by Marc Courtenay
Acxiom Looks To Sell Its $271 Million Datacenter Biz, According To Sources by 451 Research: Inorganic Growth
2 Cheap Car Stocks To Buy For 2014 by JF Global Investing
Bear Of The Day: Rentech Nitrogen by Zacks Investment Research
Bull Of The Day: Alliance Fiber Optic by Zacks Investment Research
Staples Is A Free Cash Flow Machine by The Investment Doctor
2013 Natural Gas Transportation Portfolio: November Update by Michael Fitzsimmons
Cramer's Picks
Cramer's Lightning Round - Philip Morris Has Stopped Smoking (12/2/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - Hey, Hey, Ho, Ho, John Chambers Has To Go (12/2/13) by SA Editor Miriam Metzinger
Insider Ownership
Monolithic Power Systems: 6 Different Insiders Have Sold Shares During The Last 30 Days by Markus Aarnio
IPO Analysis
China's Long IPO Freeze To End Next Month by Peter Fuhrman
Brixmor Properties Stock Price May Benefit From Expiration Of Quiet Period by Don Dion
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario